As of the latest Form 4 filed Jun 29, 2026.
What Capricor Therapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 31 most recent filings for CAPR.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-29 | 2026-06-25 | Bergmann Anthony CHIEF FINANCIAL OFFICER | SSale | −24.1K | $30.38 | $732K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Bergmann Anthony, CHIEF FINANCIAL OFFICER | MExercise | +24.1K | $3.18 | $76.6K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Krasney Karen EVP, GENERAL COUNSEL | SSale | −24.1K | $30.38 | $732K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +24.1K | $3.18 | $76.6K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-24 | Bergmann Anthony CHIEF FINANCIAL OFFICER | SSale | −400.00 | $30.00 | $12.0K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-24 | Bergmann Anthony, CHIEF FINANCIAL OFFICER | MExercise | +400.00 | $3.18 | $1.27K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-24 | Krasney Karen EVP, GENERAL COUNSEL | SSale | −400.00 | $30.00 | $12.0K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-24 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +400.00 | $3.18 | $1.27K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Bergmann Anthony CHIEF FINANCIAL OFFICER | SSale | −500.00 | $30.00 | $15.0K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Bergmann Anthony, CHIEF FINANCIAL OFFICER | MExercise | +500.00 | $3.18 | $1.59K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Krasney Karen EVP, GENERAL COUNSEL | SSale | −500.00 | $30.00 | $15.0K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +500.00 | $3.18 | $1.59K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Bergmann Anthony CHIEF FINANCIAL OFFICER | MExercise | +3.00K | $1.39 | $4.17K | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-13 | Litvack Frank Director | MExercise | +3.94K | $1.39 | $5.47K | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Bergmann Anthony CHIEF FINANCIAL OFFICER | SSale | −25.0K | $31.70 | $793K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Bergmann Anthony, CHIEF FINANCIAL OFFICER | MExercise | +25.0K | $3.18 | $79.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Krasney Karen EVP, GENERAL COUNSEL | SSale | −25.0K | $31.70 | $793K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +25.0K | $3.18 | $79.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-03 | 2026-04-02 | Sabar Karimah Es Director | SSale | −7.53K | $32.00 | $241K | Yes (planned) | Form 4 ↗ |
| 2026-04-03 | 2026-04-02 | Sabar Karimah Es, Director | MExercise | +7.53K | $3.18 | $23.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-04-01 | Sabar Karimah Es Director | SSale | −53.7K | $31.03 | $1.67M | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-04-01 | Sabar Karimah Es, Director | MExercise | +53.7K | $4.86 | $261K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Sabar Karimah Es, Director | SSale | −61.3K | $30.17 | $1.85M | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Sabar Karimah Es, Director | MExercise | +61.3K | $4.86 | $298K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Bergmann Anthony CHIEF FINANCIAL OFFICER | SSale | −25.0K | $30.13 | $753K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Bergmann Anthony, CHIEF FINANCIAL OFFICER | MExercise | +25.0K | $3.18 | $79.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Krasney Karen EVP, GENERAL COUNSEL | SSale | −25.0K | $30.12 | $753K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +2.82K | $3.18 | $8.96K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +21.5K | $3.74 | $80.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-31 | Krasney Karen, EVP, GENERAL COUNSEL | MExercise | +693.00 | $1.39 | $963.27 | Yes (planned) | Form 4 ↗ |
| 2026-03-27 | 2025-12-30 | Krasney Karen EVP, GENERAL COUNSEL | MExercise | +2.50K | $1.39 | $3.47K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CAPR’s full analysis or the market-wide insider trading feed. The tabs above jump to CAPR’s other SEC data.
Source: SEC Form 4 filings for CAPR, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.